Spire Wealth Management - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 173 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
Spire Wealth Management ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$16,247
+16.5%
2,091
+45.1%
0.00%0.0%
Q2 2023$13,949
-11.7%
1,4410.0%0.00%0.0%
Q1 2023$15,793
+263116.7%
1,4410.0%0.00%
Q4 2022$6
-99.9%
1,4410.0%0.00%
-100.0%
Q3 2022$11,000
-42.1%
1,441
-21.7%
0.00%0.0%
Q2 2022$19,000
-17.4%
1,8410.0%0.00%0.0%
Q1 2022$23,000
-46.5%
1,841
-1.1%
0.00%0.0%
Q4 2021$43,000
+26.5%
1,861
+20.8%
0.00%0.0%
Q3 2021$34,000
+70.0%
1,5410.0%0.00%0.0%
Q2 2021$20,000
+17.6%
1,541
+18.1%
0.00%
Q1 2021$17,0001,3050.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders